Webinar Sponsored by
As gene-modified cell therapies advance to address new indications, the need for rapid development of robust manufacturing processes becomes increasingly important. Process optimization sets the stage for clinical and commercial manufacturing and plays a foundational role in decreasing time to market and lowering costs of goods (COGS).
This webinar presents a series of case studies that take a Design of Experiments (DOE) approach to develop process knowledge.The studies demonstrate rapid optimization of T-cell expansion in a miniaturized, automated multi-parallel setup as well as the phenotypic analysis of CAR-T cells with donor clustering.
Kevin Kellner is an Advanced Therapies Expert at Sartorius. He holds a Ph.D. from Dublin City University and a M.Sc. in Bioprocess Development from Mannheim University of Applied Sciences. Kevin's Ph.D. thesis focused on gene editing technologies as well as cell line development with a strong emphasis on molecular and cell biology. He joined Sartorius over 4 years ago and was responsible for process and technology development for cell therapies in previous roles.